MEI Pharma Stock News

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against MEI Pharma, Inc. ("MEI Pharma" or "the Company") (NASDAQ: MEIP) and cer

Los Angeles, California--(Newsfile Corp. - August 11, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against MEI Pharma, I

New York, New York--(Newsfile Corp. - August 11, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MEI Pharma, Inc. ("MEI Pharma" or the "Company") (NASDAQ:

LOS ANGELES, CA / ACCESSWIRE / August 11, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against MEI Pharma, Inc.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of MEI Pharma, Inc. (NASDAQ: MEIP) between August 2, 2017 an

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of MEI Pha

Pomerantz LLP announces that a class action lawsuit has been filed against MEI Pharma, Inc. ("MEI" or the "Company") (NASDAQ: MEIP) and certain of its officers. The class action, filed in United State

MEI Pharma (MEIP) will provide financial updates when it reports fourth-quarter fiscal 2020 results.

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

MEIP just disclosed its licensee will discontinue Pracinostat development sending shares down below $3.

NEW YORK, NY / ACCESSWIRE / July 15, 2020 / Pomerantz LLP is investigating claims on behalf of investors of MEI Pharma, Inc. ("MEI Pharma" or the "Company") (MEIP). Such investors are advised to cont

Diversified Trust Co bought a new position in MEI Pharma Inc (NASDAQ:MEIP) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissio

Investors of MEI Pharma (MEIP) trudged off to the 4th of July celebrations in a downbeat mood. In last week’s final session, shares declined by 18.5%.The announcement that MEI and its collaboration